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Abstract
The Thomsen-Friedenreich (TF or T) antigen, Galb1-3GalNAca1-O-Ser/Thr, is the core 1 structure of O-linked mucin type
glycans appearing in tumor-associated glycosylation. The TF antigen occurs in about 90% of human cancer cells and is a
potential ligand for the human endogenous galectins. It has been reported that human galectin-1 (Gal-1) and galectin-3
(Gal-3) can perform their cancer-related functions via specifically recognizing TF antigen. However, the detailed binding
properties have not been clarified and structurally characterized. In this work, first we identified the distinct TF-binding
abilities of Gal-1 and Gal-3. The affinity to TF antigen for Gal-3 is two orders of magnitude higher than that for Gal-1. The
structures of Gal-3 carbohydrate recognition domain (CRD) complexed with TF antigen and derivatives, TFN and GM1, were
then determined. These structures show a unique Glu-water-Arg-water motif-based mode as previously observed in the
mushroom galectin AAL. The observation demonstrates that this recognition mode is commonly adopted by TF-binding
galectins, either as endogenous or exogenous ones. The detailed structural comparisons between Gal-1 and Gal-3 CRD and
mutagenesis experiments reveal that a pentad residue motif (
51AHGDA
55) at the loop (g1-L4) connecting b-strands 4 and 5
of Gal-1 produces a serious steric hindrance for TF binding. This motif is the main structural basis for Gal-1 with the low
affinity to TF antigen. These findings provide the intrinsic structural elements for regulating the TF-binding activity of Gal-1
in some special conditions and also show certain target and approach for mediating some tumor-related bioactivities of
human galectins.
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Introduction
Galectins are a family of lectins, which is characterized by the
affinity for recognizing b-galactoside-containing oligosaccharides
through the evolutionarily conserved carbohydrate recognition
domain (CRD) [1–4]. The CRD is constituted of a consensus
sequence of about 130 amino acids shared by all members of the
family [5]. To date, at least 15 mammalian galectins have been
identified [3], which can be further divided into three sub-families
according to their general structures [5]. Among them, galectin-1
(Gal-1) and galectin-3 (Gal-3) are widely studied and best
characterized.
Galectin-1 is a 14.5 kDa proto-type galectin with one unique
CRD, and forms a non-covalent homodimer [4]. Gal-3 is a
31 kDa chimera-type galectin. It is composed of unusual tandem
repeats at the N-terminus and CRD domain at the C-terminus [5].
The molecule used in this study is a truncated CRD domain of
Gal-3, which will be called as Gal-3 CRD here after. As
endogenous galectins, they can exist in the cytoplasm and nucleus
through passive diffusion or active transportation [6–7], or on the
plasma membrane surface as the components of the extracellular
matrix [8]. So far, many of the intracellular and extracellular
functions of Gal-1 and Gal-3 have been identified [9–10]. Among
others, cancer-associated activities have been gained much
attention. It has been reported that Gal-1 and Gal-3 exert their
cancer-related processes through specifically recognizing the
Thomsen-Friedenreich (TF) antigen [11–15].
TF antigen, Galb1-3GalNAca1-O-Ser/Thr, is the core 1
structure of O-linked mucin type glycans. The intact structure of
TF antigen consists of three moieties: an N-acetyl galactose
(GalNAc) linking with a galactose (Gal) and a Ser/Thr residue. It
is known that TF antigen occurs in ,90% of all human cancer
cells in cancer and pre-cancerous conditions [16]. It has been
reported that cell surface glycoproteins with TF antigen play an
important role in the regulation of cancer cell proliferation [17–
18]. The structures of two galectins, CGL2 and N-terminal
domain of galectin-9, complexed with TF disaccharide have been
reported [19–20], but they did not show any interactions between
the galectins and the GalNAc moiety unique for TF antigen. Most
recently, the structure of TF antigen complexed with an anti-
tumor galectin AAL from the edible mushroom Agrocybe aegerita
[21] has been reported to provide a first look at the recognition
mode between an exogenous galectin and TF antigen, which is
unique in a conservative Glu-water-Arg-water structural motif.
Though several structures of human Gal-1 [22–24] and Gal-3
CRD [25–28] with different ligands have been determined, there
is no report on the binding properties of the human endogenous
galectins with TF antigen based on the structural characterization.
Here we report the identification of the distinct TF-binding
properties of Gal-1 and Gal-3 CRD and the crystal structures of
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25007Gal-3 CRD complexed with TF antigen and derivatives, TFN (TF
p-nitrophenyl) and GM1 pentasaccharide (Galb1-3GalNAcb1-
4[NeuAca2-3]Galb1-4Glc), respectively. The results show a
conservative TF-binding mode based on the Glu-water-Arg-water
motif for the human endogenous galectins, and also reveal
essential differences of TF-binding activities between Gal-1 and
Gal-3 CRD and the main structural bases for their distinctions.
The mutagenesis further identified the observation based on the
structures. It sheds a new insight into the relationship between the
endogenous galectins and TF antigen.
Results and Discussion
Distinct TF-binding properties for Gal-1 and Gal-3 in vitro
The isothermal titration calorimetry (ITC) assays (Fig. 1A, 1B)
show that Gal-1 and Gal-3 CRD possess distinct TF-binding
properties. In detail, Gal-3 and Gal-1 bind to TF antigen with
dissociation constants (Kd) of 47 mM and 4 mM (Fig. 1A, 1B),
respectively, which showed that the affinity to TF antigen for Gal-
3 CRD is two orders of magnitude higher than that for Gal-1. Gal-
3 also binds to two TF derivatives, TFN and GM1, with Kd of
65 mM (Fig. 1C) and 57 mM (Figure S1), respectively. However,
the ITC assays showed that Gal-1 does not bind TFN (Fig. 1E) or
GM1 glycan (Figure S1) at all. A parallel assay for Gal-1 binding
lactose was performed, which showed that the affinity at
Kd=48 mM was compatible to the previous data [29]. The
parameters determined by ITC assay are summarized in Table 1.
The surface plasmon resonance (SPR) assays further confirm TF-
containing glycan GM1 can bind to Gal-3, but not Gal-1. The
registered curves obtained automatically from different sensorgrams
show that Gal-3 CRD can be efficiently captured by the sensor chip
surface through binding to the biotin labeled GM1 pentasaccharide
and quickly dissociated to the baseline level (Fig. 2A). Analysis of
steady state affinity model identified that the Kd is 62 mM, which is
identical to the ITC data (Table 1). However, the signal curves
referencingofGal-1 bindingwith biotinlabeled GM1isnegative.In
Figure 1. The distinct TF-binding specificities measured by ITC assay at 298 K. ITC measurements using TF antigen titrating native Gal-3
CRD (A) and Gal-1 (B) identify their distinct binding properties. The binding curves of Gal-3 (C) and Gal-3-g1-L4 (D) titrated by TFN show the mutant
Gal-3-g1-L4 exhibits very lower affinity to TFN. (E) The red curve of Gal-1 titrated by TFN shows native Gal-1 can not recognize with TFN. (F) The
measured curve of Gal-1-g3-L4 titrated by TFN shows the mutant can bind and interact with TFN.
doi:10.1371/journal.pone.0025007.g001
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concentrations did not interact with GM1 (Fig. 2B).
In a word, both ITC and SPR assays identified that Gal-3, but
not Gal-1, binds TF antigen and its derivatives with a relative high
affinity, which show that Gal-1 and Gal-3 CRD possess distinct
TF-binding properties.
Crystal structures of Gal-3 CRD complexed with TF
antigen and derivatives show a conservative TF-binding
mode
Gal-3 CRD in complex with TF antigen, lactose, TFN or GM1
were crystallized and their crystal structures were then determined
by using the molecular replacement method with Gal-3 CRD
structure (PDB ID 2NN8) [25] as the search model. The crystal
structures of Gal-3 CRD in the presence of TF antigen, lactose,
TFN or GM1 were determined at 2.0 A ˚, 2.0 A ˚, 1.9 A ˚ and 1.8 A ˚,
respectively. The statistics of data collection and structural
refinement are summarized in Table 2. However, no complex
crystals were obtained in co-crystallization of Gal-1 with TF
antigen, TFN or GM1. These further conform that Gal-1 and
Gal-3 have distinct binding properties for TF antigen and TF-
containing ligands.
The general folds of Gal-3 CRD in these complexes show a high
similarity to the previously reported structures [25] with Ca atoms
root mean square deviation (r.m.s.d) of 0.33 A ˚, 0.32 A ˚, 0.45 A ˚
and 0.37 A ˚, respectively. In the complex structures, there are two
Gal-3 CRD monomers binding with glycans in an asymmetric unit
(Fig. 3A). The CRD adopts a typical galectin fold in which six-
stranded (S1–S6) and five-stranded (F1–F5) antiparallel b-sheets
jointly formed a b-sandwich structure. The S1–S6 b-strands
constitute a concave surface on which TF antigen and other
glycans are bound. All these structural features are like those
previously reported [25–28]. In the present structures, the residues
involving in TF-binding are located on S4–S6 b-strands and the
loop connecting S4 and S5 (Fig. 3B). Electron density maps show
that TF antigen, TFN and GM1 in the complexes are all well
ordered (Fig. 3C) and carbohydrate rings of TFs are in the chair
conformations.
As the core 1 structure O-linked mucin type glycan, an intact
TF antigen consists of three moieties: an N-acetyl galactose
(GalNAc) linking with a galactose (Gal) and a Ser/Thr residue
(Galb1-3GalNAca1-O-Ser/Thr). The moiety of GalNAc is unique
for TF antigen. In the structure of Gal-3 CRD-TF complex, TF
antigen is bound to the concave pocket formed by S4–S6 b-strands
with the insertion of b-galactose ring into a wedge like cavity. The
Gal moiety of TF antigen interacts with residues His158, Asn160,
Arg162, Asn174, Trp181 and Glu184 via the hydrogen bonds or
van der waals contacts (Fig. 3E). The recognition way for Gal
moiety is basically identical to those observed in other Gal-3 CRD
related structures [25–28].
For the GalNAc moiety of TF antigen, a unique recognition
mode is observed, which is consisted of a hydrogen bond network
includingtwo watermolecules, W1 and W2 (Fig. 4).In thisnetwork,
residue Arg186 interacts with atom O1 on the carbohydrate ring of
GalNAc moiety via water molecule W1, while residue Glu165
contributes to recognition with the N-acetyl group through water
molecule W2. In addition, these two paths are closely connected
with each other via the hydrogen bonds between residues Arg186
and Glu165 and two water molecules. The Arg186-water-Glu165-
water motif-based network forms a unique paradigm, which was
firstly reported in the mushroom galectin AAL-TF complex [21], to
specifically recognize TF antigen. In the structures of Gal-3 CRD
complexed with TFN or GM1 (Fig. 5A, 5B), the Arg186-water-
Glu165-water motif-based hydrogen bond network involving in the
recognition with GalNAc moiety of TF disaccharide is very
conservative. Gal-3 CRD recognizes the TF disaccharide moiety
of GM1, not the lactose moiety as previously supposed [30].
Moreover, in all known structures of galectins complexed with non-
TF ligands, there is no such unique recognition mode to be found.
Thestructure-basedsequencealignmentsofthegalectinspotentially
interacting with TF antigen show that the two residues Arg and Glu
essential for TF-recognition are also conservative (Fig. 5D). These
observations cooperatively show that the specific recognition mode
should be commonly adopted by TF-binding galectins, either as
endogenous or exogenous ones.
The structural basis for distinct TF-binding property of
Gal-1
Structural superimpositions of Gal-1 structures (PDB ID 1W6N,
1W6M and 1GZW [22]) with Gal-3 CRD-TF antigen complex
Table 1. Summary data of measured parameters for Gal-1, -3 and mutants interacting with TF antigen or TF-derivatives from ITC
and SPR assays at 298 K.
ITC SPR
Kd (mM) -DH (kcal/mol) DS (cal/mol/deg) N, stochiometry Kd (mM)
Gal-1- TF antigen 4000 26.3 277.2 1.00
Gal-1- TFN No affinity
Gal-1- GM1 No affinity No affinity
Gal-1-g3-L4-TFN 719 1.5 9.4 1.00
Gal-1-g3-L4-GM1 568 10.3 219.8 1.00 Low affinity
Gal-3-TF antigen 47 1.9 13.5 1.04
Gal-3-TFN 65 (100%) 4.6 3.8 1.21
Gal-3-GM1 57 (100%) 4.0 6.0 1.06 62 (100%)
Gal-3-g1-L4-TFN 543 (12%) 3.9 1.9 1.00
Gal-3-g1-L4-GM1 415 (14%) 3.2 4.7 1.00 397 (16%)
Errors in Kd range from 4% to 12%. Errors in DH are less than 2%. In the assays of TF titrating Gal-1 and two mutants, the stochiometry is fixed with a value of 1; in other
measurements, errors in N value are less than 8%. Square distance numbers came from fitting procedure.
doi:10.1371/journal.pone.0025007.t001
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including the main TF-binding location consisted of b-strands S4,
S5 and S6, are very similar. However, it is interesting to find that
the loop (L4) between S4 and S5 takes evidently different
conformation and stereo-chemistry in Gal-1 and Gal-3 (Fig. 6).
Loop L4 of Gal-1 (g1-L4) consists of a pentad residue motif,
51AHGDA
55, whereas the corresponding one (g3-L4) of Gal-3
constitutes with a tetrad residue motif,
165ENNR
168. In turn, loop
g1-L4 of Gal-1 is folded rather inner so that the relative cavity is
narrower for TF antigen binding. The essentially restricted factor
for TF binding comes from the unique residue, His52. After
modeling a GalNAc group unique for TF antigen instead of the
glucose moiety in Gal-1-lactose complex structure, the atom O of
N-acetyl group makes close contacts with the imidazole ring of
residue His52 by a distance of 1.11 A ˚ (Fig. 6). Evidently, the steric
hindrance of residue His52 appeared at loop g1-L4 would block
Gal-1 from binding with TF-containing ligands and push them
away. Besides, residue His52 lies on an II-type b-turn, which is
stabilized by the hydrogen bond between the carbonyl group of
residue Ala51 and the amino group of residue Asp54. Most
importantly, residue His52 is one of major residues contributing to
binding the b-Gal moiety. It participates in the stacking contacts
with the atoms C29,O 2 9 and O4 bridging galactose and glucose. It
offers van der waals interactions on one face. Residue Trp68
Figure 2. SPR analysis of the binding specificities for Gal-1, -3 CRD and mutants to immobilized GM1-biotin pentasaccharide at
298 K. (A) The binding curves measured at different concentrations of Gal-3 CRD and the steady state affinity to biotin labeled GM1 pentasaccharide.
(B) The sensorgram response profiles for Gal-1 at different concentrations show no interaction between Gal-1 and GM1-biotin. (C) The sensorgram
curves and steady state analysis illustrate the mutant Gal-3-g1-L4 with lower affinity to GM1-biotin. (D) The measured curves show the mutant Gal-1-
g3-L4 acquires the binding ability to GM1-biotin.
doi:10.1371/journal.pone.0025007.g002
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the other face. Both His52 and Trp68 together align the b-Gal
moiety. This is a common way for Gal-1 recognizing the b-
galacto-glycans in different species [22–24,31–32]. Therefore, the
conformation of His52 is definite in Gal-1 structure. All together
described above cooperatively make the stable conformation and
orientation of residue His52 at loop g1-L4 as a unique intrinsic
structural characteristic for Gal-1. Gal-1 can bind with b-galactose
or lactose ligand (Fig. 7A, 7B), but filtrate out the TF-containing
glycans (Fig. 7C). Correspondingly, locations and orientations of
the residues Asp54 and Arg73 critical for TF-binding are also
remarkably changed in Gal-1, in turn to destroying the
conservative TF-binding mode as observed in Gal-3 (Fig. 7D).
Mutagenesis analysis identified the intrinsic structural
element for low TF-binding ability of Gal-1
To identified the main structural elements for TF-binding
ability, the mutants of Gal-1 and Gal-3 CRD with inter exchanged
loop L4 motifs were constructed and named as Gal-1-g3-L4 (Gal-
1-
51ENNR
54) and Gal-3-gl-L4 (Gal-3 CRD-
165AHGDA
169),
respectively. ITC assays show that mutant protein Gal-1-g3-L4,
excluding residue His52, dramatically acquires the binding
abilities to TFN and GM1 pentasaccharide with Kd of 719 mM
(Fig. 1F) and 568 mM (Figure S1D), respectively. SPR assays also
confirm that Gal-1-g3-L4 can bind to biotin-labeled GM1
(Fig. 2D). Compared with the native Gal-1, this is a qualitative
leap. On the other hand, ITC assays show very low affinity to TF
derivatives for mutant Gal-3-g1-L4 (Fig. 1D, S1B). The dissoci-
ation constants (Kd) of Gal-3-g1-L4 to TFN and GM1 are
543 mM and 415 mM, respectively (Table 1), which show that
affinities of the mutant protein to TFN and GM1 are respectively
reduced to 12% and 14% compared to the native Gal-3.
Meanwhile, SPR assays (Fig. 2C) show the affinity of mutant
Gal-3-g1-L4 to biotin-labeled GM1 is decreased to 16% compared
to the native Gal-3. These observations from the mutagenesis
identify that the L4 motifs are the key intrinsic structural elements
for distinct TF-binding abilities between Gal-1 and Gal-3.
It is also noticed that mutant Gal-3-g1-L4 still keeps certain TF-
binding abilities to TFN and GM1, which are even rather higher
than that of mutant Gal-1-g3-L4. Sequence alignments and
structural superposition reveal that residues located closely to the
loop L4 are not identical in Gal-1 and Gal-3. The differences of
Table 2. Data collection, processing and structural refinement statistics for Gal-3 CRD complexed with ligands.
Crystal G3C-lactose G3C-TF G3C-TFN G3C-GM1
PDB code 3AYE 3AYA 3AYD 3AYC
Data collection
Wavelength (A ˚) 1.5418 1.5418 0.9793 0.9793
Space group P1 P1 P3221 P1
Unit cell parameters
a, b, c (A ˚) 32.64, 51.67, 60.10 32.72, 51.33, 59.77 50.73, 50.73, 106.78 32.54, 51.64, 59.67
a, b, c (u) 64.37, 86.25, 80.47 64.70, 85.33, 80.33 90, 90, 120 64.44, 85.23, 81.04
Resolution (A ˚) 32.19-2.00 (2.11-2.00) 32.25-2.00 (2.11-2.00) 40.62-1.90 (2.00-1.90) 29.28-1.80 (1.90-1.80)
Subunits/asymmetric unit 2 2 1 2
Unique reflections 22,109 21,917 13,046 31,267
Completeness (%) 93.8 (91.1) 93.6 (90.9) 99.4 (98.8) 97.5 (96.3)
Redundancy 2.0 (2.0) 3.9 (3.9) 9.7 (5.7) 3.4 (3.4)
Mean I/s (I) 12.7 (7.4) 21.7 (13.7) 29.4 (15.4) 10.9 (6.8)
Rmerg (%) 2.9 (5.8) 4.2 (6.7) 5.8 (7.6) 8.3 (13.7)
Refinement
R-factor 17.5 19.9 18.2 17.0
Rfree-factor 21.0 23.8 21.7 20.1
Average B-factor for overall, water,
ligand (A ˚2)
24.1, 36.7, 31.7 21.6, 36.8, 36.1 23.9, 38.5, 20.8 17.2, 30.7, 19.9
Protein atoms 2172 2172 1086 2172
Water molecules 358 424 245 456
Atoms of ligands 46 66 70 74
RMSDs from ideal model
Bond (A ˚) 0.006 0.024 0.007 0.008
Angles (u) 1.5 1.7 1.5 1.8
Ramachandran plots
Most favored regions (%) 84.1 81.5 84.5 84.1
Allowed regions (%) 15.9 18.5 15.5 15.9
Disallowed regions (%) 0 0 0 0
Values in parentheses are for the highest resolution shell.
doi:10.1371/journal.pone.0025007.t002
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the loop g1-L4 so as to release the steric hindrance raised from
His52 somewhat. Therefore, for mutant Gal-3-gl-L4, the loop g1-
L4 could partly but not fully block TF from binding. Besides, the
fluorescence polarization assay showed that Gal-3 had a specific
affinity to galactose moiety in some galactose-containing ligands
[33–34], which may also occur in mutant Gal-3-g1-L4 so as to
contribute to its remained affinities to TFN and GM1. In case of
Gal-1, there are van der waals interactions between the side chain
of residue His52 and the Gal moiety of lactose as described above.
The mutation of Gal-1-g3-L4, excluding residue His52, will
reduce the binding affinities to galactose and lactose. ITC assays
illustrate that the Kd of Gal-1-g3-L4 to lactose is 298 mM, which
confirm that mutant Gal-1-g3-L4 shows a very lower affinity to
lactose. Thus, though mutant Gal-1-g3-L4 gains the binding
ability to TFN or GM1, the affinity appears at a low level.
It has been reported that Gal-1 could exert its cancer-related
functions through the specific recognition with TF antigen. Our
findings may provide a special way by which TF antigen could be
recognized via modification of the pentad motif (
51AHGDA
55)t o
trigger a conformational change of loop g1-L4 to that as g3-L4 of
Gal-3, so as to render the TF-binding ability of Gal-1, in vivo.
Conclusion Remarks
In this study, we firstly identified that Gal-1 and Gal-3 possess
distinct TF-binding abilities. The structures of Gal-3 CRD
complexed with TF antigen and its derivatives show a unique
binding mode based on the Glu-water-Arg-water motif for TF-
recongnition as observed in the mushroom antitumor galectin
AAL. The structural comparisons and sequence alignments show
that the unique TF-binding mode observed in Gal-3 CRD-TF
complex should be commonly adopted in TF-binding galectins,
either as endogenous or exogenous ones. The detailed structural
analyses and following mutagenesis experiments identify a pentad
residue motif (
51AHGDA
55) of the g1-L4 loop for the low TF-
binding affinity of Gal-1, which prompts the intrinsic structural
elements for regulating the TF-binding activities of Gal-1 and Gal-
3. The findings provide a new target and approach for mediating
the tumor-related activities of human galectins and shed lights on
the possible way, by which the TF-binding ability of Gal-1 could
be regulated under special conditions.
Materials and Methods
Purification and crystallization
The genes of Gal-1 and Gal-3 CRD were cloned on the pET-
22b vector without a His-tag. The recombinant plasmids were
transformed into Escherichia coli strain BL21 (DE3) for expres-
sion. The proteins were purified on a lactosyl Sepharose column
essentially as described previously [4], and then on a Hiload
Superdex75 16/60 column (from GE Healthcare) to remove the
lactose. The purified proteins were concentrated to 30 mg/ml in
solution buffer containing 10 mM PBS, 100 mM NaCl and 8 mM
b-Mercaptoethanol.
The mutants, Gal-1-g3-L4 and Gal-3-g1-L4, were designed by
exchanging two loops, g1-L4 and g3-L4. These mutants were
constructed using Quick Change Site Directed Mutagenesis
method, and then the proteins were expressed and purified as
above procedures.
Crystals of Gal-3 CRD binding ligands were obtained from
drops containing equal volumes of the protein solution buffer with
10 mM TF antigen (a gift from the CFG), TFN (from Merk) or
GM1 pentasaccharide (from Santa cruz) and reservoir buffer
composed of 2 M Ammonium sulfate, 0.1 M Bis-Tris pH5.5–6.0,
8m Mb-Mercaptoethanol, using the hanging drop vapor diffusion
method at room temperature. Crystals of Gal-3 CRD in complex
with TFN generally appeared after 6 hours and grew to full sizes
in 1–2 d. Crystals of Gal-3 CRD complexed with TF antigen or
GM1 pentasaccharide were acquired through the micro-seeding
method.
Figure 4. The specific interaction and binding mode in Galectin-TF antigen complex. Stereo diagrams show the specific recognition for
human Gal-3 interacting with TF antigen is unique in an Arg186-Water-Glu165-Water motif-based hydrogen bond network. The hydrogen bonds are
shown as dashed lines.
doi:10.1371/journal.pone.0025007.g004
Figure 3. Overall structures of Gal-3 CRD complexed with TF antigen and its derivatives. (A) Two Gal-3 CRD-TF complex molecules in an
asymmetry unit. TF antigen bound to the CRD concave is shown in a stick model. (B) The ligands binding site in complexes Gal-3-TF antigen (B1), Gal-
3-TFN (B2) and Gal-3-GM1 (B3), which show a conservative location at the concave formed by b-strands S4, S5, S6 and a loop L4 connecting S4, S5. (C)
Fo-Fc electron density maps around TF (C1), TFN (C2) and GM1 (C3) with two conservative water molecules (contoured at 3.0 s). (D, E) Interactions
between Gal-3 CRD and TF antigen or TF moiety in TFN and GM1, in which the GalNAc and Gal moieties are shown in green and yellow, respectively.
doi:10.1371/journal.pone.0025007.g003
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Crystals of Gal-3 CRD complex with ligands were soaked into the
reservoir solution supplemented with 10% (v/v) glycerol as cryo-
protectant for 15–20 s, and then flash cryo-frozen to 85 K for data
collection. Data of Gal-3 CRD-TF and Gal-3 CRD-lactose were
collectedon theR-Axis IV++ ImagePlate detectoratthe wavelength
of 1.5418 A ˚ using Rigaku rotating anode X-ray generator in house.
Data of Gal-3 CRD-TFN and Gal-3 CRD-GM1 were collected at
the wavelength of 0.9793 A ˚ on Beamline 17 U synchrotron,
Shanghai Synchrotron Radiation Facility. Exposure time per image
was 180 s in house or 0.8 s on synchrotron.
The dada were integrated using the program MOSFLM [35] and
then scaled by SCALA from CCP4 package [36]. Structures were
determined using Phaser [37] with the molecular replacement method
using the structure of Gal-3 CRD (PDB ID 2NN8) [25] as the search
model. The ligands were manually added and adjusted according to
the remnants of electron density maps in Coot [38]. The final
refinements of structures were performed using CNS [35] and manual
adjustment alternatively. 5% of the reflections for Rfree calculations
were randomly chosen and excluded from every refinement.
ITC assay
All calorimetric experiments were performed by the ITC200
isothermal titration calorimeter (Microcal, 200 ml cell, Northampton,
GE Healthcare, America) at 298 K using 40 ml ligands titrating
200 ml galectins. The delayed time between injections is 180 s. For
every ligands, at least three titrations were done. The dissociation
constants (Kd) were calculated using the Origin Program and the
experimental data were fitted to a one-set-of-sites model.
SPR assay
The SPR assays were performed at 298 K using the BIAcore 3000
instrumentation (from GE Healthcare, Sweden). Biotin labeled GM1
pentasaccharide (from CFG) was dissolved into PBS buffer and
connected covalently onto a streptavidin (SA) chip as the immobilized
Figure 5. The conservative Arg186-Water-Glu165-Water motif-based TF-binding mode. (A, B) The specific recognition mode is conserved
in Gal-3-TFN or Gal-3-GM1 complex. (C) Consensus binding mode between galectins and TF antigen, which is unique in a water molecule mediated
hydrogen bond network. (D) Sequence alignment of carbohydrate recognition domain for human galectins. The critical residues for the binding
mode highlighted in triangles are conservative.
doi:10.1371/journal.pone.0025007.g005
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in the sample buffer (20 mM PBS, pH7.5, 0.005% Tween 20) were as
the flowing phase. Analytes with volume of 30 mla tv a r i o u s
concentrations ordered from low to high were programmed to inject
with a 30 ml/min flow rate under different sensorgrams. In order to
correct for instrumental and concentration effects, a blank flow
channel was used as reference. Specific binding analyses were
identified by subtraction of the control channel. The kinetic analyses
Figure 6. Structural superposition and comparison between the two loops, g1-L4 and g3-L4. Stereo view of the loops g1-L4 (in pink) and
g3-L4 (in cyan) show their different conformations. The residue His52 on the loop g1-L4 make close contacts with the N-acetyl group of TF antigen
with a distance of 1.1 A ˚ between atoms Cc of His52 and O of the N-acetyl group.
doi:10.1371/journal.pone.0025007.g006
Figure 7. Structural comparison of the carbohydrate recognition pockets in Gal-1 and Gal-3 binding with different ligands. (A, B) The
concave carbohydrate binding pocket in Gal-1 shows Gal-1 recognizes and binds with galactose (Gal) or alternative lactose suitably. (C) The modeled
TF antigen shows a serious spatial obstruction between its N-acetyl group and His52 on g1-L4. (D) The TF-binding pocket and the unique binding
mode conserved in Gal-3 CRD. All ligands are shown in a ball-and-stick model and carbohydrate binding pockets are illustrated as surface drawing.
doi:10.1371/journal.pone.0025007.g007
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affinity model by BIAcore T100 Evaluation software.
Protein Data Bank accession number
Coordinates and structure factors for the structures of Gal-3
CRD complexed with TF antigen, TFN and GM1 have been
deposited at the Protein Data Bank with accession codes 3AYA,
3AYD, 3AYC, respectively.
Supporting Information
Figure S1 ITC measurements of Gal-3 CRD, Gal-1 and
two mutants titrated by GM1 pentasaccharide at 298K.
Titrating curves of Gal-3 (A) and Gal-3-g1-L4 (B) show the
different affinities to GM1 pentasaccharide. (C) The red curve
shows native Gal-1 can not recognize and interact with GM1. (D)
The black curve of Gal-1-g3-L4 titrated by GM1 shows the
mutant gains the TF-binding ability.
(TIF)
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